What is the problem?
Women with developmental disabilities (DD) tend to have poorer health than other groups. Previous research by the H-CARDD program and others shows that they are less likely to get screened for reproductive cancers than those in the general population. Pregnancy and motherhood also pose a challenge. Women in general tend to have increased risk of certain side effects from antipsychotic medications, which are the drugs women with DD are most commonly prescribed. However, no research has investigated this issue among women with DD.
How is H-CARDD helping?
The H-CARDD program aims to understand and describe health disparities in women with DD in Ontario. Our research focus is on three areas that are a high priority for these women:
- Screening for reproductive cancers;
- Maternal reproductive health and pregnancy; and
- Gender differences in side effects from medications used to treat behaviour problems and psychiatric problems among individuals with DD.
The H-CARDD program is in keeping with the vision of the Ontario Women's Health Framework, which aims to improve health and well-being for Ontario women, especially those who are disadvantaged, through targeted approaches and system change.
For more information, please contact
Simone Vigod, MD, MSc, FRCPC
Scientist, Women's College Research Institute
Staff Psychiatrist, Women's College Hospital
Assistant Professor, Department of Psychiatry, University of Toronto
Phone: 416 323 6400
Email: simone.vigod@wchospital.ca
Virginie Cobigo, PhD, C.Psych.
Associate Professor, School of Psychology & Centre for Research on Educational and Community Services, University of Ottawa
Phone: 613 562 5800, Ext. 7753
Email: virginie.cobigo@uottawa.ca
